杆菌感染与宿主代谢平衡之间的相互作用:综合性综述
Junzhao Ye1, Ting Feng2, Lei Su3
1Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, PR China.
Helicobacter
|October 23, 2023
概括
杆菌 (H. pylori) 感染会改变宿主的新陈代谢,可能导致代谢性疾病. 本综述探讨了H. pylori,宿主新陈代谢和疾病发展之间的复杂联系.
科学领域:
- 微生物学 微生物学
- 代谢科学 代谢科学
- 胃肠病学 胃肠病学
背景情况:
- 人体肠道微生物群显著影响宿主新陈代谢和疾病发展.
- 杆菌 (H. pylori) 感染会影响局部胃组织和宿主系统代谢.
- 了解H. pylori的代谢调节是治疗相关疾病的关键.
研究的目的:
- 审查当前关于慢性H. pylori感染和代谢性疾病之间的关联的临床证据.
- 探索H. pylori影响宿主新陈代谢的潜在分子机制.
- 突出了解H. pylori-宿主-微生物组-免疫网络的挑战.
主要方法:
- 对临床证据和现有文献的审查.
- 对代谢学研究结果的分析.
- 分子相互作用路径的合成.
主要成果:
- 杆菌感染与影响营养和铁吸收的全身代谢变化有关.
- 杆菌感染和根除可以改变胃病变中的代谢物和微生物概况.
- 受到H. pylori影响的特定代谢途径 (例如,异酸,胆固醇) 需要进一步调查癌症发生和代谢疾病.
结论:
- 慢性H. pylori感染与代谢性疾病有关,具有复杂的分子调节模式.
- 需要进一步的研究来阐明H. pylori对宿主代谢和相关疾病的直接贡献.
- 与H. pylori相关的代谢障碍的向治疗可能来自对这些相互作用的更深入理解.
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
420
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
420
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
606
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
606
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
438
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
438
Gastritis-II: Pathophysiology
348
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
348
Peptic Ulcer Disease II: Pathophysiology
468
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
468
Peptic Ulcer Disease I: Introduction
179
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
179


